Navigation Links
VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week
Date:6/15/2008

SAN DIEGO, CA, June 16, 2008 -- VaxInnate Corporation announced today that it will discuss its novel proprietary technology for producing seasonal and pandemic influenza vaccines during BIO 2008 here this week.

VaxInnate will participate in the following three BIO 2008 panel discussions:

On Tuesday, June 17th

  • "Influenza Research and Surveillance: Preparing for the Next Pandemic,"
    8:15-9:45 am in Room 29A including Robert Becker, PhD, MBA, VaxInnate's Vice President of Business Development

On Thursday, June 19th

  • "Vaccine Renaissance,"
    8:30-10:00 am, Room 29A including Dr. Robert Becker

  • "Moore's Law for Biomanufacturing: Innovation in a Maturing Biologicals Industry,"
    4:00 - 5:30 pm, Room 29B including Edward Arcuri, PhD, VaxInnate's Chief of Operations (COO)

VaxInnate's Approach

VaxInnate's novel technology has the potential to dramatically improve the potency, manufacturing capacity and cost-effectiveness of influenza vaccines.

VaxInnate's approach to developing and producing influenza vaccines is based upon a proprietary combination of toll-like receptor (TLR) mediated immune enhancement and recombinant bacterial production of vaccine antigen. This proprietary technology could significantly reduce the time required to produce supplies of influenza vaccine sufficient to meet national and even global needs.

VaxInnate's use of bacterial expression for production of influenza vaccines does not require costly expansion of manufacturing capacity, as do other influenza vaccine products. Due to its efficiency and transferability, VaxInnate's flu vaccine could instead be produced in existing biotechnology facilities that have microbial production capacity.

No other vaccine technology in use or in development today has these same potential capabilities.

Results of a Phase I study of VaxInnate's M2e universal vaccine candidate will be available this summer. The company plans to present the study data at a major scientific conference later this year and publish the data in a peer-reviewed journal.


'/>"/>

Contact: Janet Skidmore
skidmorecomm@earthlink.net
215-658-4915
VaxInnate
Source:Eurekalert

Related biology news :

1. Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization
2. Book on weeds and invasive plants discusses how to manage them using ecological approaches
3. Presidents of Iceland, Bangladesh to discuss global climate change in New Orleans
4. Art meets science: Engineer discusses his photographs in free UH lecture
5. Leading researchers and experts gather to discuss latest advancements in drug discovery
6. Japanese and German researchers meet to discuss climate change
7. Biophysical Society to host discussions on the teaching of evolution and on the energy crisis
8. MIT professor to discuss future of biofuels
9. DHS, business leaders discuss technology to protect US at Homeland Security conference
10. Wildlife Conservation Society study finds seasonal seas save corals with tough love
11. NASA technology helps predict and prevent future pandemic outbreaks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2017)... Against identity fraud with DERMALOG solutions "Made in Germany "  ... ... solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. ... ...
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, ... Simple," and 23andMe , the leading personal genetics ... choices.  Zipongo can now provide customers with personalized nutrition ... goals and biometrics, but also genetic markers impacting how ... Zipongo,s personalized food decision support platform uses biometrics ...
(Date:3/6/2017)... Calif. , March 6, 2017 ... and sales technology, today announced Predictive Sales Coach ... for infusing actionable sales intelligence into Salesforce. This ... automatically enable their sales organizations with deep knowledge ... that allow for intelligent engagement. Predictive Sales Coach ...
Breaking Biology News(10 mins):
(Date:4/25/2017)... 25, 2017 Providence ... its novel immune-modulating technology to an undisclosed global pharmaceutical ... Tregitopes, pronounced T·rej·itopes, are a set ... EpiVax CEO Annie De Groot and ... G, an autoimmune disease therapy, Tregitopes are capable ...
(Date:4/24/2017)... ... April 24, 2017 , ... It is well established ... however, the broad application of this cellular target engagement concept to drug discovery ... Cell-based thermal stabilization assays are valuable methods for particular applications, but they can ...
(Date:4/21/2017)... ... April 21, 2017 , ... The University ... first round funding to three startups through the UConn Innovation Fund. The $1.5 ... business startups affiliated with UConn. , The UConn Innovation Fund provides investments of ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... dedicated to nourishing a range of emerging technology-based businesses, recently earned a $77,518 ... Court location. , Founded in 2004, FITCI is Frederick’s first incubator. A ...
Breaking Biology Technology: